Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Non-Current Debt (2019 - 2025)

Historic Non-Current Debt for Volitionrx (VNRX) over the last 7 years, with Q3 2025 value amounting to $5.6 million.

  • Volitionrx's Non-Current Debt rose 4501.89% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 4501.89%. This contributed to the annual value of $4.0 million for FY2024, which is 904.82% up from last year.
  • Per Volitionrx's latest filing, its Non-Current Debt stood at $5.6 million for Q3 2025, which was up 4501.89% from $5.8 million recorded in Q2 2025.
  • In the past 5 years, Volitionrx's Non-Current Debt registered a high of $5.8 million during Q2 2025, and its lowest value of $1.7 million during Q2 2022.
  • For the 5-year period, Volitionrx's Non-Current Debt averaged around $3.2 million, with its median value being $2.7 million (2022).
  • Per our database at Business Quant, Volitionrx's Non-Current Debt crashed by 2147.05% in 2022 and then surged by 8396.85% in 2024.
  • Volitionrx's Non-Current Debt (Quarter) stood at $2.3 million in 2021, then rose by 22.39% to $2.8 million in 2022, then skyrocketed by 30.43% to $3.6 million in 2023, then grew by 9.05% to $4.0 million in 2024, then surged by 40.8% to $5.6 million in 2025.
  • Its last three reported values are $5.6 million in Q3 2025, $5.8 million for Q2 2025, and $5.5 million during Q1 2025.